Abstract
Purpose
To explore the relationships between macular thickness and the plasma concentrations of homocysteine, vitamin B12, folate, and other known risk factors for patients with diabetes without diabetic macular edema (DME).
Methods
Fasting venous blood samples were collected from 252 subjects (126 relatively healthy subjects with type 2 diabetes without diabetic macular edema and 126 age- and gender-matched controls). Measurement of macular thickness and volume was performed for those subjects using SD-OCT. The plasma concentrations of homocysteine, vitamin B12, folate, and other known risk factors were analyzed in all the patients and controls using multiple linear regression models.
Results
An increase in the serum levels of homocysteine was present within patients with type 2 diabetes compared to healthy individuals. The mean total plasma homocysteine levels were associated with a greater central subfield macular thickness (CSMT), average macular thickness (AMT), and average macular volume (AMV) in patients with type 2 diabetes without DME, after adjusting for age, sex, duration of diabetes, and HbA1c. Each 1 mmol/L increase in tHcy level was associated with a 6.57 µm greater CSMT (95% confidence interval [CI] 1.78, 11.36), a 4.51 µm greater AMT (95% CI 1.05, 7.98), and a 4.72 mm3 greater AMV (95% CI 1.23, 8.21).
Conclusions
Higher homocysteine levels were associated with an increased CSMT, AMT, and AMV in diabetic patients without DME. This link may indicate that patients with type 2 diabetes with increased levels of plasma tHcy are more prone to develop a clinical manifestation of DME.
Similar content being viewed by others
References
Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249–1257
Ko F, Vitale S, Chou CF, Cotch MF, Saaddine J, Friedman DS (2012) Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999–2002 and 2005–2008. JAMA 308:2361–2368
Jia WP, Pang C, Chen L et al (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50:286–292
Ikram MK, Cheung CY, Lorenzi M et al (2013) Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care 36:750–759
Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M (2013) Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 4:290–294
Klein R, Klein BE, Moss SE (1984) Visual impairment in diabetes. Ophthalmology 91:1–9
Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564
Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) The Wisconsin epidemiologic study of diabetic retinopathy XV. The long-term incidence of macular edema. Ophthalmology 102:7–16
Dong N, Xu B, Chu L, Tang X (2015) Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. PLoS ONE 10:e0125329
Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97:512–523
Navaratna D, McGuire PG, Menicucci G, Das A (2007) Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56:2380–2387
McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U (2009) Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology 116(1778–1787):e1
Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536–545
Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113
Magné J, Huneau JF, Borderie D, Mathé V, Bos C, Mariotti F (2015) Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia. Amino Acids 47:1975–1982
Wang XC, Sun WT, Yu CM et al (2015) ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IKCa and SKCa channels. Atherosclerosis 242:191–198
Lai WK, Kan MY (2015) Homocysteine-induced endothelial dysfunction. Ann Nutr Metab 67:1–12
Eren E, Ellidag HY, Aydin O, Yılmaz N (2014) Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur. J Clin Diagn Res 8:CE01–CE04
Aydin E, Demir HD, Ozyurt H, Etikan I (2008) Association of plasma homocysteine and macular edema in type 2 diabetes mellitus. Eur J Ophthalmol 18:226–232
Klein BE, Knudtson MD, Tsai MY, Klein R (2009) The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 127:1175–1182
Li J, Zhang H, Shi M, Yan L, Xie M (2014) Homocysteine is linked to macular edema in type 2 diabetes. Curr Eye Res 39:730–735
Zhang J, Ma J, Zhou N, Zhang B, An J (2015) Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies. Med Sci Monit 21:929–936
Chen S, Wang B, Dong N, Ren X, Zhang T, Xiao L (2014) Macular measurements using spectral-domain optical coherence tomography in Chinese myopic children. Invest Ophthalmol Vis Sci 55:7410–7416
Dong N, Wang B, Chu L, Xiao L (2013) Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population. Curr Eye Res 38:1153–1158
Dong N, Xu B, Tang X (2014) Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population. Invest Ophthalmol Vis Sci 55:4057–4062
Ubbink JB, Hayward Vermaak WJ, Bissbort S (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441–446
Brazionis L, Rowley K Sr, Itsiopoulos C, Harper CA, O’Dea K (2008) Homocysteine and diabetic retinopathy. Diabetes Care 31:50–56
Hoogeveen EK, Kostense PJ, Eysink PE et al (2000) Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn study. Arch Intern Med 160:2984–2990
Huang EJ, Kuo WW, Chen YJ et al (2006) Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 366:293–298
Gupta P, Sidhartha E, Tham YC et al (2013) Determinants of macular thickness using spectral domain optical coherence tomography in healthy eyes: the Singapore Chinese Eye study. Invest Ophthalmol Vis Sci 54:7968–7976
Diabetic Retinopathy Clinical Research Network, Bressler NM, Miller KM et al (2012) Observational study of subclinical diabetic macular edema. Eye (Lond) 26:833–840
Bhavsar KV, Subramanian ML (2011) Risk factors for progression of subclinical diabetic macular oedema. Br J Ophthalmol 95:671–674
Emoto M, Kanda H, Shoji T et al (2001) Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24:533–538
Passaro A, Calzoni F, Volpato S et al (2003) Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med 254:264–271
Ren H, Mu J, Ma J et al (2016) Selenium inhibits homocysteine-induced endothelial dysfunction and apoptosis via activation of AKT. Cell Physiol Biochem 38:871–882
Gundogan FC, Yolcu U, Akay F, Ilhan A, Ozge G, Uzun S (2016) Diabetic macular edema. Pak J Med Sci 32:505–510
Acknowledgements
The authors thank the support of Xiao Lin Chair in Department of Ophthalmology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No potential conflicts of interest relevant to this article were reported.
Ethical approval
The study was approved by the Ethics Committee of Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China, and was performed in accordance with the Declaration of Helsinki.
Informed consent
Each subject received a detailed information leaflet and provided informed written consent before participation.
Rights and permissions
About this article
Cite this article
Dong, N., Shi, H. & Tang, X. Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema. Int Ophthalmol 38, 737–746 (2018). https://doi.org/10.1007/s10792-017-0528-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-017-0528-0